This site is intended for healthcare professionals
News

Johnson & Johnson initiates second phase III clinical trial, ENSEMBLE 2, of JNJ-78436735 COVID-19 vaccine.

Read time: 1 mins
Last updated:20th Nov 2020
Published:20th Nov 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com